Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04683250
Title Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities ((MARGARET))
Acronym (MARGARET)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Helsinn Healthcare SA
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Chao Family Comprehensive Cancer Center TERMINATED Orange California 92868-3298 United States Details
Stanford Cancer Center TERMINATED Stanford California 94305-5826 United States Details
Massachusetts General Hospital TERMINATED Boston Massachusetts 02114 United States Details
Henry Ford Hospital TERMINATED Detroit Michigan 48202 United States Details
START Midwest - Cancer & Hematology Centers of Western Michigan TERMINATED Grand Rapids Michigan 49546 United States Details
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health TERMINATED New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center TERMINATED New York New York 10065 United States Details
The Sarah Cannon Research Institute/Tennessee Oncology TERMINATED Nashville Tennessee 37203 United States Details
The University of Texas M. D. Anderson Cancer Center TERMINATED Houston Texas 77030-4009 United States Details
National Cancer Center Hospital East RECRUITING Kashiwa-shi Chiba Japan Details
National Cancer Center Hospital RECRUITING Chuo-ku Tokyo 104-0045 Japan Details
The Cancer Institute Hospital of JFCR RECRUITING Koto-ku Tokyo 135-8550 Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field